- HK$4.57bn
- HK$2.65bn
- CNY17.90bn
- 21
- 42
- 57
- 32
Annual income statement for YSB, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6,065 | 10,094 | 14,275 | 16,972 | 17,904 |
| Cost of Revenue | |||||
| Gross Profit | 609 | 914 | 1,435 | 1,741 | 1,813 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6,631 | 10,588 | 15,761 | 20,172 | 17,878 |
| Operating Profit | -566 | -495 | -1,487 | -3,200 | 25.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -576 | -503 | -1,497 | -3,210 | 14.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -572 | -502 | -1,500 | -3,207 | 15.1 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -572 | -494 | -1,489 | -3,189 | 30 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -572 | -494 | -1,489 | -3,189 | 30 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.903 | -0.777 | -2.32 | -8.18 | 0.048 |
| Dividends per Share |